Welcome to Mathilde
We are very pleased to welcome Mathilde Faller to our team. Mathilde brings a breadth of expertise in the design and programming of modelling studies. Mathilde will primarily support the development of…
Are you ready for the Danish Medicines Council 2.0? – The appraisal process and the clinical application
Introduction In this second article, we touch upon the most significant changes made to the application process and to the clinical application and theorize on its importance in the future…
Welcome to Robert and Thomas
We are very pleased to welcome Robert Kidd and Thomas Linemann to our team. Robert provides extensive global health economic and HTA experience and is a specialist within advanced health…
Are you ready for the Danish Medicines Council 2.0? – The QALY
Introduction The implementation of a “QALY model” in the Danish Medicines Council (DMC) will have a significant impact on the assessment process. The quality adjusted life-year (QALY) is primarily used…
Are you ready for the Danish Medicines Council version 2.0?
From 2021 the Danish Medicines Council will change their assessment framework and include QALYs in their decision analytic framework. This will inherently mean a greater focus on cost-effectiveness than in…
